Call for Abstract

17th Annual Medicinal & Pharmaceutical Sciences Congress, will be organized around the theme “New research to uncover opportunities in the medical and pharmaceutical studies”

Med Pharma Congress 2018 is comprised of 16 tracks and 138 sessions designed to offer comprehensive sessions that address current issues in Med Pharma Congress 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

The Pharmaceutical Sciences are a group of interdisciplinary areas of study concerned with the design, action, delivery and disposition of drugs. They apply knowledge from Chemistry (inorganic, physical, biochemical and analytical), biology (anatomy, physiology, biochemistry, cell biology and molecular), epidemiology, statistics, chemo metrics, mathematics, physics, and chemical engineering.

  • Track 1-1Electrophoresis
  • Track 1-2Trade dress
  • Track 1-3Drug Screening and Discovery
  • Track 1-4Pharmacological Testing
  • Track 1-5Advances in Pharmaceutical Research
  • Track 1-6R&D Advancement
  • Track 1-7Principles of Good Manufacturing Practice
  • Track 1-8Digital Pharma

Pharmacology is the branch of medicine and biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within body) molecule which exerts a biochemical and/or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

  • Track 2-1Cardiovascular Pharmacology
  • Track 2-2Clinical Pharmacology
  • Track 2-3Neuropharmacology
  • Track 2-4Systems Pharmacology
  • Track 2-5Theoretical Pharmacology
  • Track 2-6Behavioral Pharmacology
  • Track 2-7Environmental Pharmacology
  • Track 2-8Ocular Pharmacology
  • Track 2-9Biochemical Pharmacology
  • Track 2-10Continental Pharmacovigilance
  • Track 2-11Good Pharmacovigilance Practice
  • Track 2-12Pharmacovigilance and Risk Management
  • Track 2-13Psychopharmacology
Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry. While developing pharmaceutical products involves many interrelated disciplines like medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc, the specific subfield of "pharmaceutical engineering" has only emerged recently as a distinct engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.
  • Track 3-1Cell and Tissue Engineering
  • Track 3-2Clinical and Biomedical Engineering
  • Track 3-3Biomaterials and Biomechanics
  • Track 3-4Bioinformatics and Computational Biology
  • Track 3-5Genetic Engineering and Genomics
  • Track 3-6Neural and Rehabilitation Engineering
  • Track 3-7Bioinstrumentation
  • Track 3-8Medical Devices and Medical Imaging
  • Track 3-9Bio-pharmaceutics

A biopharmaceutical, also known as a biological medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

  • Track 4-1Pharmacokinetics and Pharmacodynamics
  • Track 4-2Bioavailability and Bioequivalence
  • Track 4-3Bio waiver
  • Track 4-4Biological Medicine
  • Track 4-5Novel Approaches in Bio Pharmaceutics
  • Track 4-6Invivo-invitro Correlation

Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics can be defined as the technology that analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination), as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

  • Track 5-1Translational Pharmacogenomics
  • Track 5-2Applications of NGS to Pharmacogenomics
  • Track 5-3Nutrigenomics
  • Track 5-4Toxicogenomics
  • Track 5-5Biomarker Translation and Testing
  • Track 5-6Cancer Pharmacogenomics
  • Track 5-7Pharmacogenitics & Individualized Therapy
  • Track 5-8Pharmacogenomics in Clinical Therapeutics

Pharmacognosy is the study of medicinal drugs derived from plants or other natural sources. The American Society of Pharmacognosy defines pharmacognosy as "the study of the physical, chemical, biochemical and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as well as the search for new drugs from natural sources. It is also defined as the study of crude drugs. Phytochemistry is the study of phytochemicals, which are chemicals derived from plants. Specifically, phytochemistry describes the large number of secondary metabolic compounds found in plants. Many of these are known to provide protection against insect attacks and plant diseases. They also exhibit a number of protective functions for human consumers.  Phytochemistry can be considered sub-fields of botany or chemistry. Activities can be led in botanical gardens or in the wild with the aid of ethnobotany. The applications of the discipline can be for pharmacognosy, or the discovery of new drugs, or as an aid for plant physiology studies

  • Track 6-1Drugs from Natural Sources
  • Track 6-2Computational Chemistry
  • Track 6-3Molecular Drug Design
  • Track 6-4Structure Aided and Computer Aided Drug Design
  • Track 6-5Extraction Techniques
  • Track 6-6Ethnopharmacology
  • Track 6-7Marine Pharmacognosy

Pharmaceutical Toxicology explains the methodology and requirements of pre-clinical safety assessments of new medicines. With the focus on medicinal drugs, the most important safety issues of drugs are covered. This includes registration requirements of new drugs and pharmacovigilance.

  • Track 7-1Regulatory Toxicology
  • Track 7-2Analytical Toxicology
  • Track 7-3Plant Toxicology
  • Track 7-4Toxicologic Pathology
  • Track 7-5Biodegradation
  • Track 7-6Toxicokinetics

Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.

  • Track 8-1Waste Management
  • Track 8-2Product Management
  • Track 8-3Post- marketing Surveillance
  • Track 8-4Good manufacturing practices
  • Track 8-5Pharmaceutical Marketing
  • Track 8-6Pharma Companies
  • Track 8-7Pharma Manufacturing

Regulatory affairs (RA), is also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc. Regulatory affairs also has a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods)

  • Track 9-1Healthcare Regulatory Affairs
  • Track 9-2Pharmaceutical RA
  • Track 9-3Biologics and Biotechnology RA
  • Track 9-4Medical devices RA
  • Track 9-5Clinical Affairs & Regulatory Strategies
  • Track 9-6Regulatory Communications and Submissions
  • Track 9-7Global Regulatory Intelligence
  • Track 9-8Global Regulatory Strategy

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

  • Track 10-1Oral Drugs
  • Track 10-2Parental Formulations
  • Track 10-3Topical Formulations
  • Track 10-4Modified Release Formulations
  • Track 10-5Novel Drug Formulations
  • Track 10-6Oncological Formulations
  • Track 10-7Cosmetics
  • Track 10-8Veterinary Products

Nano medicine is the medical application of nanotechnology. Nano medicine ranges from the medical applications of nanomaterial’s and biological devices, to Nano electronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for Nano medicine involve understanding the issues related to toxicity and environmental impact of Nano scale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter). Functionalities can be added to nanomaterial by interfacing them with biological molecules or structures. The size of nanomaterial’ is similar to that of most biological molecules and structures; therefore, nanomaterial’s can be useful for both in vivo and in vitro biomedical research and applications. Thus far, the integration of nanomaterial with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.

  • Track 11-1Nano Materials
  • Track 11-2Biological Devices
  • Track 11-3Nano electronic Biosensors
  • Track 11-4Nano Scale Materials
  • Track 11-5Nanoscience and Technology
  • Track 11-6Molecular Nanotechnology
  • Track 11-7Bionano Interactions & Nanotoxicology
  • Track 11-8Sensors & Imaging
  • Track 11-9Nano Pharmaceutical Industry and Market

An analytical technique is a method that is used to determine the concentration of a chemical compound or chemical element. There are a wide variety of techniques used for analysis, from simple weighing (gravimetric analysis) to titrations (titrimetric) to very advanced techniques using highly specialized instrumentation. Bioanalysis is a sub-discipline of analytical chemistry covering the quantitative measurement of xenobiotics (drugs and their metabolites, and biological molecules in unnatural locations or concentrations) and biotics (macromolecules, proteins, DNA, large molecule drugs, metabolites) in biological systems.

  • Track 12-1Electro Analytical Methods
  • Track 12-2Spectroscopy
  • Track 12-3Electrophoresis
  • Track 12-4Gravimetric Analysis
  • Track 12-5Ligand Binding Assays
  • Track 12-6Mass Spectrometry
  • Track 12-7Nuclear Magnetic Resonance
  • Track 12-8Chromatographic Techniques for Drug Analysis

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.

  • Track 13-1Rational Drug Design
  • Track 13-2Computer-Aided Drug Design
  • Track 13-3Structure-Based Drug Design
  • Track 13-4Dosage Form
  • Track 13-5Route of Administration
  • Track 13-6Computational Chemistry
  • Track 13-7Medicinal Chemistry

Clinical pharmacy is the branch of pharmacy in which pharmacists provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, nurse practitioners, and other healthcare professionals.

  • Track 14-1Clinical Pharmacy and Therapeutics
  • Track 14-2Continental Pharmacovigilance
  • Track 14-3Good Pharmacovigilance Practice
  • Track 14-4Pre-Clinical and Clinical Trials
  • Track 14-5Pharmacovigilance and Risk Management
  • Track 14-6Clinical Trials on Various Disorders
  • Track 14-7Clinical Research and Statistics
  • Track 14-8Clinical Pharmacy Activities and Prescriptions
  • Track 14-9Clinical Pharmacy and Drug Reactions
  • Track 14-10Dispensing Pharmacy and Research Chemists
The pharmaceuticals and life sciences industry has been very cautious in applying digital technology to improve manufacturing and supply chain operations thus far, yet that caution is becoming a hindrance. As the pharma industry faces growing challenges including globalization, great supply chain complexity, price and cost pressure, and personalized medicine, among others digitization holds tremendous potential in helping companies adapt.
  • Track 15-1Digital Strategies in Research and Development
  • Track 15-2Digitize Pharma Operations and Supply Chains
  • Track 15-3Digital Strategies in Health Service Delivery
  • Track 15-4The Future of Pharmaceutical Digital Strategy
  • Track 15-5Telemedicine


Intellectual property (IP) refers to creations of the intellect for which a monopoly is assigned to designated owners by law. Intellectual property rights (IPRs) are the protections granted to the creators of IP, and include trademarks, copyright, patents, industrial design rights, and in some jurisdictions trade secrets. Artistic works including music and literature, as well as discoveries, inventions, words, phrases, symbols, and designs can all be protected as intellectual property.

  • Track 16-1Patents
  • Track 16-2Copyright
  • Track 16-3Industrial Design Rights
  • Track 16-4Trademarks
  • Track 16-5Trade secrets